Position in VTRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,483,211
+$463,848 QoQ
Shares Held
471,235
-9.3% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#146
of 1,020 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $134,224,123 across 32 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
370,571 | $41,111,146 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
113,293 | $19,094,401 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
442,383 | $10,887,045 | |
| 4 | VTRS |
Viatris Inc
This page
|
471,235 | $7,483,211 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
13,289 | $7,200,378 | |
| 6 | ZTS |
Zoetis Inc.
|
89,660 | $6,442,967 | |
| 7 | ALKS |
Alkermes plc.
|
118,998 | $6,235,494 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
685,570 | $5,429,713 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,483,211 | 471,235 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $7,019,363 | 519,568 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $5,560,580 | 446,633 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,681,671 | 371,886 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $11,591,969 | 1,298,093 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,338,651 | 1,301,797 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $5,166,463 | 414,977 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $5,223,314 | 449,898 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $4,922,443 | 463,071 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $5,129,554 | 429,611 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $4,678,516 | 431,996 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $4,024,555 | 408,170 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $4,163,794 | 417,214 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $4,394,828 | 456,843 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $4,886,936 | 439,078 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $3,576,993 | 419,835 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $4,441,749 | 424,236 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,782,248 | 439,545 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,055,513 | 447,562 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,412,361 | 473,237 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,873,303 | 480,987 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,744,016 | 482,750 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,563,085 | 617,027 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||